DK1318820T3 - Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel - Google Patents

Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel

Info

Publication number
DK1318820T3
DK1318820T3 DK01972033T DK01972033T DK1318820T3 DK 1318820 T3 DK1318820 T3 DK 1318820T3 DK 01972033 T DK01972033 T DK 01972033T DK 01972033 T DK01972033 T DK 01972033T DK 1318820 T3 DK1318820 T3 DK 1318820T3
Authority
DK
Denmark
Prior art keywords
drug containing
cardiovascular agent
containing xenon
subanesthetic
concentrations
Prior art date
Application number
DK01972033T
Other languages
Danish (da)
English (en)
Inventor
Carsten Pilger
Nicola Horn
Peter Neu
Klemens Thoma
Fridtjof Schucht
Jan-Hinrich Baumert
Klaus Hecker
Matthias Reyle-Hahn
Rolf Rossaint
Arnold Coppin
Original Assignee
Air Liquide Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Deutschland Gmbh filed Critical Air Liquide Deutschland Gmbh
Application granted granted Critical
Publication of DK1318820T3 publication Critical patent/DK1318820T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01972033T 2000-09-14 2001-09-10 Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel DK1318820T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10045845A DE10045845A1 (de) 2000-09-14 2000-09-14 Xenon als Arzneimittel
PCT/EP2001/010402 WO2002022141A2 (de) 2000-09-14 2001-09-10 Xenon als arzneimittel

Publications (1)

Publication Number Publication Date
DK1318820T3 true DK1318820T3 (da) 2005-05-23

Family

ID=7656443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01972033T DK1318820T3 (da) 2000-09-14 2001-09-10 Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel

Country Status (8)

Country Link
EP (2) EP1570852A3 (pt)
AT (1) ATE288275T1 (pt)
AU (1) AU2001291844A1 (pt)
DE (2) DE10045845A1 (pt)
DK (1) DK1318820T3 (pt)
ES (1) ES2236305T3 (pt)
PT (1) PT1318820E (pt)
WO (1) WO2002022141A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420650T1 (de) * 2002-06-12 2009-01-15 Air Liquide Deutschland Gmbh Cerebrale protektion mit einem xenonhaltigen gas
US20050244508A1 (en) * 2002-06-12 2005-11-03 Messer Griesheim Anti-spasmodic comprising xenon
DE10336778B4 (de) * 2002-08-10 2010-09-16 Air Liquide Deutschland Gmbh Stabilisierung eines Patienten mit einem xenonhaltigen Gas
DE10336768B4 (de) * 2002-08-10 2010-09-09 Air Liquide Deutschland Gmbh Medikament zur Verbesserung der Sauerstoffutilation
DE10336777B4 (de) * 2002-08-10 2012-05-31 Air Liquide Deutschland Gmbh Medikament zur kardialen Stabilisierung
WO2004052337A2 (de) * 2002-12-06 2004-06-24 Michael Georgieff Nasale pharmazeutische präparation enthaltend eine lipophile flüssige oder gasförmige wirksubstanz
FR2948878B1 (fr) * 2009-08-04 2012-08-31 Air Liquide Utilisation du xenon pour traiter l'hypersensibilite a la douleur
RU2506944C1 (ru) * 2012-09-24 2014-02-20 Александр Юрьевич Верховский Способ повышения трансдермальной проницаемости лечебных или косметических препаратов для наружного применения, способ введения в кожу газообразного ксенона
CN110354067A (zh) * 2013-03-15 2019-10-22 德克萨斯州大学系统董事会 富含稀有气体的液体及其制备和使用方法
RU2019116383A (ru) * 2016-10-31 2020-11-30 Нобилис Терапьютикс, Инк. Лечение тревожных расстройств и усиление противотревожных воздействий с помощью применения смесей, содержащих инертный газ
US20230117859A1 (en) * 2020-03-25 2023-04-20 The Brigham And Women`S Hospital, Inc. Inhaled xenon therapy in neurodegenerative disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601366A (en) * 1977-06-21 1981-10-28 Nat Res Dev Lasers
FR2538704B1 (fr) * 1983-01-03 1986-02-28 France Prod Oxygenes Co Produit de contraste des images en tomodensitometrie
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel

Also Published As

Publication number Publication date
DE50105258D1 (de) 2005-03-10
ATE288275T1 (de) 2005-02-15
EP1318820B1 (de) 2005-02-02
PT1318820E (pt) 2005-06-30
WO2002022141A3 (de) 2002-08-22
DE10045845A1 (de) 2002-04-04
AU2001291844A1 (en) 2002-03-26
EP1318820A2 (de) 2003-06-18
EP1570852A3 (de) 2005-11-23
WO2002022141A2 (de) 2002-03-21
ES2236305T3 (es) 2005-07-16
EP1570852A2 (de) 2005-09-07

Similar Documents

Publication Publication Date Title
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
LTPA2011011I1 (lt) Stabilūs farmacinių tirpalų preparatai, skirti slėginiams dozuotiems inhaliatoriams
EP1330238A4 (en) PHARMACEUTICAL FORMULATIONS CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND PROTON PUMP INHIBITOR
NO2013003I2 (no) Forbindelser som NS3-serinproteaseinhibitorer for hepatitt C-virus, farmasøytiske preparater og anvendelse av forbindelsene til fremstilling av et medikament
DK1318820T3 (da) Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
DE60019167D1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
DE60308997D1 (de) Formulierungen zur inhalation
DE60031504D1 (de) Fluticasonpropionat arzneizubereitung
DE50303646D1 (de) Feste pharmazeutische Zusammensetzung enthaltend Tilidinhydrochlorid